.) This project is focused on the investigation of molecular mechanisms of myotonic dystrophy (DM), a disease characterized by weakness and myotonia of skeletal muscle, impaired systolic contraction of cardiac muscle, and cardiomyopathy, together with cataracts, mental retardation and endocrine abnormalities. Mutations for DM is an expanded CTG triplet repeat located in the 3' untranslated region of the myotonin protein kinase (Mt-PK) gene. The molecular mechanism of the pathogenesis of DM is unknown. The investigators recently identified a family of novel proteins with binding activities specific for triplet repeats and particular CUG-BP protein specific for RNA CUG repeats. CUG-BP protein was purified from HeLa cells and found to be identical to a novel RNA-binding protein Nab2p, which plays an essential role in the regulation of poly(A) tail length and/or nucleocytoplasmic export of mRNAs. The investigators hypothesize that CUG triplet repeat binding proteins regulate processing and transport of MRNAs containing CUG repeats such as Mt-PK mRNA and that a large increase in the number of CUG triplet repeat impairs processing/transport of these mRNAs and is responsible for the pathogenesis of DM. In the first specific aim, the investigators will examine the potential role of CUG-BP/Nab60 in the regulation of the Mt-PK mRNA processing and transport. Stable clonal cell lines containing over-expressed (CUG)n repeats or over-expressed CUG-BP/Nab50 will be used to determine whether alteration of CUG-BP/Nab50 protein alters the expression of Mt-PK mRNA from the mutant allele of the Mt.-PK gene.
In Specific Aim 2, they propose to search for other MRNAs that are regulated by CUG-BP/Nab50.
In specific Aim 3, CUG-BP/Nab50 RNA and protein levels and its CUG binding activity will be determine in cultured cells and tissues derived from normal controls, DM patients, and Mt-PK knock-out mice.
In Specific Aim 4, the propose to knock out the CUG-BP/Nab50 gene in a mouse and determine the biochemical, physical and morphological phenotypic manifestations. If the hypotheses are correct, one would expect to see some features similar to the DM phenotype. Results of these experiments provide insight into the function of this newly identified family of proteins and determine their role in pathogenesis. of DM.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR044387-05
Application #
6375038
Study Section
Biological Sciences 2 (BIOL)
Program Officer
Lymn, Richard W
Project Start
1997-09-01
Project End
2002-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
5
Fiscal Year
2001
Total Cost
$237,208
Indirect Cost
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Wei, Christina; Stock, Lauren; Valanejad, Leila et al. (2018) Correction of GSK3? at young age prevents muscle pathology in mice with myotonic dystrophy type 1. FASEB J 32:2073-2085
Jones, Karlie; Wei, Christina; Schoser, Benedikt et al. (2015) Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5. Proc Natl Acad Sci U S A 112:8041-5
Hong, Il-Hwa; Lewis, Kyle; Iakova, Polina et al. (2014) Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments. J Biol Chem 289:1106-18
Bachinski, Linda L; Baggerly, Keith A; Neubauer, Valerie L et al. (2014) Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies. Neuromuscul Disord 24:227-40
de Haro, Maria; Al-Ramahi, Ismael; Jones, Karlie R et al. (2013) Smaug/SAMD4A restores translational activity of CUGBP1 and suppresses CUG-induced myopathy. PLoS Genet 9:e1003445
Meola, Giovanni; Jones, Karlie; Wei, Christina et al. (2013) Dysfunction of protein homeostasis in myotonic dystrophies. Histol Histopathol 28:1089-98
Timchenko, Lubov (2013) Molecular mechanisms of muscle atrophy in myotonic dystrophies. Int J Biochem Cell Biol 45:2280-7
Jones, Karlie; Timchenko, Lubov; Timchenko, Nikolai A (2012) The role of CUGBP1 in age-dependent changes of liver functions. Ageing Res Rev 11:442-9
Jones, Karlie; Wei, Christina; Iakova, Polina et al. (2012) GSK3? mediates muscle pathology in myotonic dystrophy. J Clin Invest 122:4461-72
Jones, Karlie; Jin, Bingwen; Iakova, Polina et al. (2011) RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2. Am J Pathol 179:2475-89

Showing the most recent 10 out of 32 publications